Cargando…
Inhibition of dengue virus replication by novel inhibitors of RNA-dependent RNA polymerase and protease activities
Dengue virus (DENV) is the leading mosquito-transmitted viral infection in the world. With more than 390 million new infections annually, and up to 1 million clinical cases with severe disease manifestations, there continues to be a need to develop new antiviral agents against dengue infection. In a...
Autores principales: | Pelliccia, Sveva, Wu, Yu-Hsuan, Coluccia, Antonio, La Regina, Giuseppe, Tseng, Chin-Kai, Famiglini, Valeria, Masci, Domiziana, Hiscott, John, Lee, Jin-Ching, Silvestri, Romano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010079/ https://www.ncbi.nlm.nih.gov/pubmed/28776445 http://dx.doi.org/10.1080/14756366.2017.1355791 |
Ejemplares similares
-
Indolylarylsulfones, a fascinating story of highly potent human immunodeficiency virus type 1 non-nucleoside reverse transcriptase inhibitors
por: Famiglini, Valeria, et al.
Publicado: (2018) -
Focus on Chirality of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors
por: Famiglini, Valeria, et al.
Publicado: (2016) -
Emerging Direct Targeting β-Catenin Agents
por: Nalli, Marianna, et al.
Publicado: (2022) -
N-Pyrrylarylsulfones with High Therapeutic Potential
por: Famiglini, Valeria, et al.
Publicado: (2017) -
Recent Advances in Drug Discovery for Triple-Negative Breast Cancer Treatment
por: Masci, Domiziana, et al.
Publicado: (2023)